NCT05635643
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05635643
Title Study of CHS-114 in Participants With Advanced Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Coherus Oncology, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Stanford Cancer Center Palo Alto California 94305 United States Details
Emory Winship Cancer Institute Atlanta Georgia 30308 United States Details
University of Louisville Louisville Kentucky 40202 United States Details
University of Maryland Greenebaum Comprehensive Cancer Center Baltimore Maryland 21201 United States Details
University of Michigan Ann Arbor Michigan 48104 United States Details
Barbara Ann Karmanos Cancer Institute - Karmanos Cancer Center Detroit Michigan 48201 United States Details
Washington University St Louis Missouri 63110 United States Details
University of Cincinnati Cincinnati Ohio 45219 United States Details
Vanderbilt-Ingram Cancer Center Nashville Tennessee 37203 United States Details
START- San Antonio San Antonio Texas 78229 United States Details
START Mountain West Valley City Utah 84119 United States Details
University of Washington/Fred Hutchinson Cancer Center Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field